1 line
3.8 KiB
JSON
1 line
3.8 KiB
JSON
{"Administration site erythema": 2.869194137840116, "Administration site swelling": 23.25520607601861, "Adnexa uteri pain": 10.18539310419225, "Amenorrhoea": 5.74424857538131, "Axillary mass": 2.0692154251853023, "Axillary pain": 5.923419121732695, "Breast pain": 3.6338927728874273, "COVID-19 immunisation": 11.405679586884942, "COVID-19 pneumonia": 3.190515885320516, "Catarrh": 2.745513515077157, "Cervicobrachial syndrome": 9.523450420830487, "Chillblains": 6.294648697721823, "Deafness unilateral": 2.5264058805001435, "Dizziness postural": 2.4012530381011645, "Dysmenorrhoea": 6.480535167294683, "Endometriosis": 3.361286785043206, "Erythema nodosum": 2.103756079704656, "Facial paralysis": 2.4609955054033974, "Formication": 4.293332193948601, "Headache": 2.2758392761120385, "Heavy menstrual bleeding": 4.4604050797082975, "Hemiparaesthesia": 4.068588214841811, "Immunisation reaction": 27.996419448719347, "Increased viscosity of upper respiratory secretion": 12.575984174921205, "Influenza like illness": 5.07894610531853, "Injected limb mobility decreased": 2.4147188638591595, "Injection site erythema": 3.562947684198091, "Injection site joint erythema": 34.2853694186257, "Injection site joint swelling": 78.01761768383675, "Injection site oedema": 3.20219690623795, "Injection site paraesthesia": 6.336862328560651, "Injection site rash": 5.540979609357985, "Injection site urticaria": 4.789688056225117, "Intermenstrual bleeding": 5.066267212628726, "Local reaction": 2.012589058948204, "Lymphadenitis": 5.819029557824164, "Lymphadenopathy": 5.61049618001774, "Malaise": 3.5295753164236947, "Mastitis": 2.5129546396498954, "Mechanical urticaria": 6.741333063009982, "Menometrorrhagia": 16.838608953042066, "Menstrual disorder": 3.855262478818579, "Menstruation delayed": 4.02462284743569, "Menstruation irregular": 4.90167861289466, "Muscle contractions involuntary": 2.694911661188221, "Myalgia": 3.060643776360176, "Myocarditis": 2.2646730302435576, "Myopericarditis": 5.691354817371805, "Neuralgic amyotrophy": 5.295745608554054, "Nuchal rigidity": 4.97499408177851, "Odynophagia": 8.676878750232142, "Oligomenorrhoea": 7.137204516220444, "Oral herpes": 2.801354546156851, "Paraesthesia": 2.274504805122576, "Pelvic pain": 4.219909553365011, "Periarthritis": 2.688440220452068, "Pericarditis": 2.076286857995606, "Polymenorrhoea": 4.689739456924431, "Polymyalgia rheumatica": 2.793531682255277, "Premenstrual pain": 3.7570987821666, "Premenstrual syndrome": 13.002946199411834, "Pyrexia": 5.228916100004721, "Skin reaction": 3.3949171632973134, "Superficial vein thrombosis": 2.3429111653225085, "Temperature regulation disorder": 19.86856228141124, "Tinnitus": 3.143353513750849, "Urticaria chronic": 2.4439496973921404, "Uterine haemorrhage": 5.110606431904274, "Uterine pain": 7.186007053708341, "Vaccination site cellulitis": 12.33439933654798, "Vaccination site discomfort": 4.526527069205722, "Vaccination site eczema": 16.21391064668421, "Vaccination site erythema": 4.8991115299175645, "Vaccination site haematoma": 12.779116524115253, "Vaccination site induration": 14.449464873076607, "Vaccination site inflammation": 105.10557487413904, "Vaccination site joint erythema": 48.33606911024823, "Vaccination site joint pain": 6.832184473845358, "Vaccination site lymphadenopathy": 37.69888942720888, "Vaccination site mass": 10.830665678169686, "Vaccination site movement impairment": 7.109649302215687, "Vaccination site oedema": 12.561405836200535, "Vaccination site pain": 8.839697699495801, "Vaccination site paraesthesia": 13.653520435062642, "Vaccination site pruritus": 8.54038701845057, "Vaccination site rash": 27.52946239533655, "Vaccination site reaction": 12.233662358853032, "Vaccination site swelling": 2.7676956969680897, "Vaccination site urticaria": 16.703885216285972, "Vaccination site warmth": 7.892420125927168, "Vertigo": 2.1247053925457484, "Vestibular neuronitis": 2.743255666796249} |